Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease-Reference-Cited by-同舟云学术

Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease

Published:2014-02 Issue:2 Volume:146 Page:383-391
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Walters Thomas D.,Kim Mi-Ok,Denson Lee A.,Griffiths Anne M.,Dubinsky Marla,Markowitz James,Baldassano Robert,Crandall Wallace,Rosh Joel,Pfefferkorn Marian,Otley Anthony,Heyman Melvin B.,LeLeiko Neal,Baker Susan,Guthery Stephen L.,Evans Jonathan,Ziring David,Kellermayer Richard,Stephens Michael,Mack David,Oliva-Hemker Maria,Patel Ashish S.,Kirschner Barbara,Moulton Dedrick,Cohen Stanley,Kim Sandra,Liu Chunyan,Essers Jonah,Kugathasan Subra,Hyams Jeffrey S.

Funder

Crohn's and Colitis Foundation of America

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease;Markowitz;Clin Gastroenterol Hepatol,2006

2. Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease;Wilson;J Pediatr Gastroenterol Nutr,2010

3. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease;Markowitz;Gastroenterology,2000

4. Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms;Pfefferkorn;J Pediatr Gastroenterol Nutr,2009

5. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children;Hyams;Gastroenterology,2007

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in disease characteristics and treatment exposures between paediatric and adult‐onset inflammatory bowel disease using a registry‐based cohort;Alimentary Pharmacology & Therapeutics;2024-09-10

2. Eicosatetraynoic Acid Regulates Profibrotic Pathways in an Induced Pluripotent Stem Cell–Derived Macrophage-Human Intestinal Organoid Model of Crohn’s Disease;Journal of Crohn's and Colitis;2024-08-30

3. Predictors of improvement in disease activity in childhood and adolescent Crohn’s disease: an analysis of age, localization, initial severity and drug therapy — data from the Saxon Registry for Inflammatory Bowel Disease in Children in Germany (2000–2014);European Journal of Pediatrics;2024-08-03

4. Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long‐term extension results;Journal of Pediatric Gastroenterology and Nutrition;2024-05-27

5. Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort;Gastroenterology;2024-05